Triple

T22421725
Position Surface form Disambiguated ID Type / Status
Subject Mitsubishi Tanabe Pharma E554263 entity
Predicate hasSubsidiary P254 FINISHED
Object Mitsubishi Tanabe Pharma America
Mitsubishi Tanabe Pharma America is the U.S.-based subsidiary of Mitsubishi Tanabe Pharma Corporation focused on developing and commercializing innovative pharmaceutical therapies for the American market.
 E554263 NE FINISHED

How this triple was built (4 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Mitsubishi Tanabe Pharma America | Statement: [Mitsubishi Tanabe Pharma, hasSubsidiary, Mitsubishi Tanabe Pharma America]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: Mitsubishi Tanabe Pharma America
Context triple: [Mitsubishi Tanabe Pharma, hasSubsidiary, Mitsubishi Tanabe Pharma America]
  • A. Mitsubishi Tanabe Pharma
    Mitsubishi Tanabe Pharma is a Japanese pharmaceutical company known for developing prescription drugs and biopharmaceuticals, including treatments for neurological and autoimmune diseases.
  • B. Eisai
    Eisai is a Japanese pharmaceutical company known for developing treatments in neurology and oncology, including Alzheimer’s disease therapies.
  • C. Eisai
    Eisai was a Japanese Buddhist monk of the Kamakura period best known for introducing Rinzai Zen and promoting tea culture in Japan.
  • D. Chugai Pharmaceutical
    Chugai Pharmaceutical is a major Japanese research-based pharmaceutical company known for its innovative biopharmaceuticals and strategic alliance with Roche.
  • E. Takeda Pharmaceutical Company
    Takeda Pharmaceutical Company is a leading global biopharmaceutical firm headquartered in Japan, focused on developing innovative medicines in areas such as oncology, gastroenterology, neuroscience, and rare diseases.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Mitsubishi Tanabe Pharma America
Triple: [Mitsubishi Tanabe Pharma, hasSubsidiary, Mitsubishi Tanabe Pharma America]
Generated description
Mitsubishi Tanabe Pharma America is the U.S.-based subsidiary of Mitsubishi Tanabe Pharma Corporation focused on developing and commercializing innovative pharmaceutical therapies for the American market.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07 
Target entity: Mitsubishi Tanabe Pharma America
Target entity description: Mitsubishi Tanabe Pharma America is the U.S.-based subsidiary of Mitsubishi Tanabe Pharma Corporation focused on developing and commercializing innovative pharmaceutical therapies for the American market.
  • A. Mitsubishi Tanabe Pharma chosen
    Mitsubishi Tanabe Pharma is a Japanese pharmaceutical company known for developing prescription drugs and biopharmaceuticals, including treatments for neurological and autoimmune diseases.
  • B. Eisai
    Eisai is a Japanese pharmaceutical company known for developing treatments in neurology and oncology, including Alzheimer’s disease therapies.
  • C. Eisai
    Eisai was a Japanese Buddhist monk of the Kamakura period best known for introducing Rinzai Zen and promoting tea culture in Japan.
  • D. Chugai Pharmaceutical
    Chugai Pharmaceutical is a major Japanese research-based pharmaceutical company known for its innovative biopharmaceuticals and strategic alliance with Roche.
  • E. Takeda Pharmaceutical Company
    Takeda Pharmaceutical Company is a leading global biopharmaceutical firm headquartered in Japan, focused on developing innovative medicines in areas such as oncology, gastroenterology, neuroscience, and rare diseases.
  • F. None of above.

Provenance (5 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69e11e4f2d0c819091aa3558ea2ee630 completed April 16, 2026, 5:37 p.m.
NER Named-entity recognition batch_69f1594b08d88190bb61a30397d0ffa5 completed April 29, 2026, 1:05 a.m.
NED1 Entity disambiguation (via context triple) batch_6a0b0c66eaa88190a58d646620de8612 completed May 18, 2026, 12:56 p.m.
NEDg Description generation batch_6a0b0d8a6024819093541ef45e3a22b4 completed May 18, 2026, 1 p.m.
NED2 Entity disambiguation (via description) batch_6a0b0de37c208190ac16ec35b1a8edee completed May 18, 2026, 1:02 p.m.
Created at: April 16, 2026, 8:46 p.m.